Long-term observation of vitrectomy without subretinal hemorrhage management for massive v

Long-term observation of vitrectomy without subretinal hemorrhage management for massive vitreous hemorrhage secondary to polypoidal

choroidal vasculopathy

Zhi-Xi Li; Yi-Jun Hu; Alp Atik; Lin Lu; Jie Hu

【期刊名称】《国际眼科杂志：英文版》 【年(卷),期】2024(012)012

【摘要】AIM: To describe the long-term observation of vitrectomy without subretinal hemorrhage(SRH) management for massive vitreous hemorrhage(VH) secondary to polypoidal choroidal vasculopathy(PCV). METHODS: This is a retrospective, consecutive case series. A total of 86 eyes of 86 patients with >14d of massive VH associated with PCV were included. All patients underwent vitrectomy without SRH management, followed by intravitreal ranibizumab injections and/or photodynamic therapy(PDT) as needed. The main outcome measures were best-corrected visual acuity(BCVA), postoperative adverse events and the recurrence of VH. RESULTS: The average follow-up period was 25.5±9.2 mo(range 12-35 mo). Mean BCVA at baseline(2.16±0.39 logM AR)had improved significantly, both 3 mo after surgery(1.42±0.66 log MAR, P<0.001) and by the last visit(1.23±0.74 logM AR, P<0.001). The common postoperative complications included macular subretinal fibrosis in 14 eyes(16.3%) and ciliary body detachment in 4

eyes(4.7%).Nineteen eyes(22.1%) received following treatment with ranibizumab injections without/with PDT, and 15(17.4%)were resolved. Four eyes(4.7%) had recurrent hemorrhage during the follow-up period. In multiple regression analysis,thicker SRH(beta=0.33, P=0.025) in the preoperative

B-scan

and

the

presence

of

foveal

subretinal

fibrosis(beta=0.28, P=0.018) in the follow up were associated with poor postoperative

BCVA.

CONCLUSION:

Vitrectomy

without

SRH

management for massive VH secondary to PCV improved/stabilized visual function in the long-term observation. Eyes presenting with thicker SRH preoperatively and forming foveal subretinal fibrosis in the follow-up period tended to have worse BCVA. 【总页数】6页(P.1859-1864)

【关键词】polypoidal choroidal vasculopathy; vitreous hemorrhage; vitrectomy; visual acuity

【作者】Zhi-Xi Li; Yi-Jun Hu; Alp Atik; Lin Lu; Jie Hu

【作者单位】State Key Laboratory of Ophthalm ology Zhongshan Ophthalmic Center Sun Yat-sen University Guangzhou 510060 Guangdong Province China; Aier School of Ophthalmology Central South University Changsha 410000 Hunan Province China; Royal Victorian Eye and Ear Hospital Melbourne 3000 Australia 【正文语种】中文 【中图分类】R73

【文献来源】

https://www.zhangqiaokeyan.com/academic-journal-cn_international-journal-ophthalmology_thesis/0201277595896.html 【相关文献】

1.One-year outcomes of intravitreal conbercept combined rescue therapy for polypoidal choroidal vasculopathy in a Chinese population: a real-life clinical data [J], Hui-Jun Qi[1]; En-Zhong Jin[1]; Ming-Wei Zhao[1]

2.Choroidal Analysis of Polypoidal Choroidal Vasculopathy by Spectral Domain Optical Coherence Tomography [J], Chunyi Wei; Ran Liu; Jiaqing Li; Yu Yang; Xiaoyan Ding

3.Giant non-pulsatile polypoidal choroidal vasculopathy [J], Elton Lik Tong Tay; Augustinus Laude

4.Effects of three consecutive monthly intravitreal injection of ranibizumab for polypoidal choroidal vasculopathy in Korea [J], Young; Gun; Park; Seungbum; Kang; Young; Jung; Roh

5.Combined therapy versus anti-vascular endothelial growth factor monotherapy for polypoidal choroidal vasculopathy： a Meta-analysis [J], Long-Hui Han[1]; Li-Fei Yuan[1]; Xu Liang[2]; Xin Jia[1]; Ming-Lian Zhang[1]

以上内容为文献基本信息，获取文献全文请下载